1 2 3

CARDIOVASCULAR DIAGNOSTICS
A NEW AGE IS DAWNING

Cardiovascular diseases -- including heart attack, stroke, congestive heart failure, hypertension and a host of other conditions -- are by far the biggest killers in the industrialized world, accounting for nearly half of all deaths.  In the U.S. alone, at least $150 billion is spent annually on treating cardiovascular diseases.

Despite these staggering figures, in vitro diagnostics (IVDs) for cardiovascular diseases have long been a minor part of the picture. By one estimate, cardiovascular IVDs account for less than 3% of the world IVD market. Cardiovascular diseases typically haven't lent themselves to diagnosis via blood markers. Moreover, the cumbersome existing diagnostic tools were considered adequate in an era when treatments for heart attacks and strokes were largely limited to prevention and supportive care. Clinicians could be content to wait hours for a definitive diagnosis.

But all this is changing. This ground-breaking report tells you why and how.

1 2 3